Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

271 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
Joffe H, LaCroix AZ, Cohen L. Joffe H, et al. JAMA Intern Med. 2015 Apr;175(4):658-9. doi: 10.1001/jamainternmed.2014.7997. JAMA Intern Med. 2015. PMID: 25844753 No abstract available.
Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, Lacroix AZ, Freeman EW. Joffe H, et al. Menopause. 2013 Mar;20(3):261-8. doi: 10.1097/GME.0b013e31826d3108. Menopause. 2013. PMID: 23435022 Free PMC article. Clinical Trial.
The role of sleep difficulties in the vasomotor menopausal symptoms and depressed mood relationships: an international pooled analysis of eight studies in the InterLACE consortium.
Chung HF, Pandeya N, Dobson AJ, Kuh D, Brunner EJ, Crawford SL, Avis NE, Gold EB, Mitchell ES, Woods NF, Bromberger JT, Thurston RC, Joffe H, Yoshizawa T, Anderson D, Mishra GD. Chung HF, et al. Psychol Med. 2018 Nov;48(15):2550-2561. doi: 10.1017/S0033291718000168. Epub 2018 Feb 12. Psychol Med. 2018. PMID: 29429422 Free PMC article. Clinical Trial.
Characterizing the trajectories of vasomotor symptoms across the menopausal transition.
Tepper PG, Brooks MM, Randolph JF Jr, Crawford SL, El Khoudary SR, Gold EB, Lasley BL, Jones B, Joffe H, Hess R, Avis NE, Harlow S, McConnell DS, Bromberger JT, Zheng H, Ruppert K, Thurston RC. Tepper PG, et al. Menopause. 2016 Oct;23(10):1067-74. doi: 10.1097/GME.0000000000000676. Menopause. 2016. PMID: 27404029 Free PMC article. Clinical Trial.
Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.
Newton KM, Reed SD, Guthrie KA, Sherman KJ, Booth-LaForce C, Caan B, Sternfeld B, Carpenter JS, Learman LA, Freeman EW, Cohen LS, Joffe H, Anderson GL, Larson JC, Hunt JR, Ensrud KE, LaCroix AZ. Newton KM, et al. Menopause. 2014 Apr;21(4):339-46. doi: 10.1097/GME.0b013e31829e4baa. Menopause. 2014. PMID: 24045673 Free PMC article. Clinical Trial.
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE, Sternfeld B, Caan B, Freeman EW, LaCroix AZ, Tinker LF, Booth-Laforce C, Larson JC, Anderson GL. Cohen LS, et al. Menopause. 2014 Apr;21(4):347-54. doi: 10.1097/GME.0b013e31829e40b8. Menopause. 2014. PMID: 23982113 Free PMC article. Clinical Trial.
Shifting Paradigms About Hormonal Risk Factors for Postmenopausal Depression: Age at Menopause as an Indicator of Cumulative Lifetime Exposure to Female Reproductive Hormones.
Joffe H, Bromberger JT. Joffe H, et al. JAMA Psychiatry. 2016 Feb;73(2):111-2. doi: 10.1001/jamapsychiatry.2015.2701. JAMA Psychiatry. 2016. PMID: 26746695 No abstract available.
Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine.
Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, Cohen LS. Joffe H, et al. J Clin Psychiatry. 2007 Jun;68(6):943-50. doi: 10.4088/jcp.v68n0619. J Clin Psychiatry. 2007. PMID: 17592922 Clinical Trial.
271 results
Jump to page
Feedback